Ryan Braun got off on a “technicality?” Bull!

114 Comments

In almost all cases, the people who say that someone “got off on a technicality” or took advantage of a “loophole” really mean “I think the SOB was guilty and because of that I don’t care if the proper safeguards and protocols were followed!”  It’s a ridiculous stance.

Ridiculous because procedures such as chain of custody and the proper handling of samples — which were not followed in Braun’s case — exist for a reason. That reason is not, contrary to popular grunting, to make it harder for decent prosecutors or authorities to do their jobs. It’s to ensure the integrity of the system. And, in this case, the integrity of the sample. Every detail that is not adhered to presents another opportunity for a sample to be tainted, lost or otherwise compromised. When that happens the test itself is, by definition, unreliable and any reference to what it may or may not have shown is utterly beside the point.

And while that, in this case, may work to Braun’s benefit, in the long run adherence to those procedures is critical to the integrity and efficacy of the drug testing process. And that’s far more important than whatever this means for one man’s drug test.

The response I expect to that is “well, just because procedures weren’t followed doesn’t mean that Braun didn’t take something!”  My response: you’re right.  We don’t know that. And we can’t know that, because the testing program is not nor can it reasonably be expected to be one that decides absolute guilt or absolute innocence.  In this it’s just like the criminal justice system which never determines actual innocence. It determines the lack of guilt. It does this because the burden is on the accuser and not the accused, same as with the drug testing procedure.

Except in the drug testing world the burden is way, way lower than “beyond a reasonable doubt.”  All MLB has to do is take a sample and test it properly, while adhering to a relatively simple set of procedures.  If MLB, in this case, could not be bothered to do even that, then neither it nor anyone else has cause to label Ryan Braun a drug user.

Ryan Braun got off on a technicality?  Bull.  Major League Baseball half-assed it and failed to adhere to the standards it set up for itself.  In that case I have no problem considering Braun to be the less culpable party.  Anyone who says otherwise is more interested in assumptions and the casting of aspersions than they are in a rigorous and legitimate drug testing regime.

UPDATE: Here’s a copy of the drug agreement.  The term “chain of custody” appears in it 33 times. Beginning on page 38, there are detailed instructions to those who collect and handle samples.  In light of this, to suggest that the chain of custody issues are “minor” or “mere technicalities” is absurd. These procedures are a fundamental feature of the system, not some petty and annoying loophole.

Report: Rangers agree to six-year extension with Rougned Odor

Getty Images
Leave a comment

The Rangers have reportedly agreed to a six-year, $49.5 million extension for second baseman Rougned Odor, according to Jon Heyman of FanRag Sports and Evan Grant of the Dallas Morning News. The extension comes with a club option for a seventh year, Heyman adds.

It’s close to the six-year, $52.5 million extension Jason Kipnis netted with the Indians in 2014, a sum Odor was rumored to be seeking during contract negotiations over the last two years. Granted, the circumstances are a little different this time around. Both players signed extensions on the cusp of their fourth year in the major leagues, but at 27 years old, Kipnis was coming off of an All-Star campaign and a career-high 4.5 fWAR performance. Odor, meanwhile, saw mixed results in 2016, batting 33 home runs and putting up 2.0 fWAR while struggling to stay consistent at the plate and exhibiting poor defense.

According to MLB.com’s T.R. Sullivan, Odor previously agreed to a $563,180 salary for 2017. Depending on when the extension kicks in, it should cover all three of Odor’s arbitration-eligible seasons and two seasons of potential free agency. The team has yet to confirm the extension.

2017 Preview: Minnesota Twins

Getty Images
Leave a comment

Between now and Opening Day, HardballTalk will take a look at each of baseball’s 30 teams, asking the key questions, the not-so-key questions, and generally breaking down their chances for the 2017 season. Next up: The Minnesota Twins.

Which iteration of the Twins will we get in 2017? The second-place contenders of 2015, blazing their way through the standings with 83 wins and a handful of hot prospects? The burnouts of 2016, flopping to the bottom of the division with 103 losses and a lineup held in place by Brian Dozier and, well, Brian Dozier? Or something in between?

Finishing dead last has its perks, namely a first-round draft pick and the feeling that things can’t be quite as bad as they were the year before. Unfortunately for the Twins, the only major preparation they made for the 2017 season came in the form of a front office shakeup. Derek Falvey assumed control of the club in October, bringing GM Thad Levine into the fold in November as the club assumed a more analytics-friendly approach toward the rebuilding movement.

When it came to roster revisions, however, there wasn’t much moving or shaking this winter. Third baseman Trevor Plouffe, catcher Kurt Suzuki and left-handers Tommy Milone and Pat Dean vacated their spots on the roster. Falvey avoided some of the bigger bats and bullpen arms in free agency and opted to sign backstop Jason Castro and journeyman reliever Ryan Vogelsong instead.

By and large, the core of the Twins’ roster remained the same. Center fielder Byron Buxton, infielder/outfielder Michael Sano and right-hander Jose Berrios still form the nucleus of the club’s top prospects. Middle infielder Brian Dozier will also return in 2017, though he appears to be on borrowed time with the Twins after putting up monster numbers in the second half of 2016. Ervin Santana will head the rotation again, accompanied by fellow veterans Hector Santiago, Kyle Gibson and Phil Hughes, while right-handed relievers Brandon Kintzler, Ryan Pressly and Matt Belisle and rehabbing lefty Glen Perkins attempt to prevent another bullpen collapse in 2017.

Without any major additions to the team (and, excepting the departure of Trevor Plouffe, any major subtractions), the Twins will look to their existing cadre of players for significant improvements in 2017. Miguel Sano is expected to take over third base in Plouffe’s absence, which will bring a welcome end to his short-lived and wholly unsuccessful experiment in right field. Brian Dozier, Jorge Polanco and Joe Mauer should round out the infield, with Byung Ho Park and Kennys Vargas currently vying for a spot as the team’s designated hitter.

The lineup is still four or five or six sluggers shy of formidable, but if Dozier can be counted on to repeat his 42-homer, 5.9 fWAR performance from 2016, there will be at least one Twin worth intentionally walking in 2017. Neither Miguel Sano nor Byron Buxton have quite found their footing against big league pitching yet, and another year spent struggling in the majors could mean another year of sub-optimal run production for the team as well. Jason Castro, who grades as an above-average defender behind the plate, is unlikely to provide any additional pop for the Twins at the plate after slashing just .210/.307/.377 through 376 PA with the Astros in 2016.

The pitching department also leaves a little to be desired in light of the league-worst 5.09 ERA they amassed last season. A veteran-heavy rotation could get a boost from the addition of fifth-starter candidate Jose Berrios, who is thought to be the favorite after fellow rotation candidate Trevor May underwent Tommy John surgery earlier this week. Right-hander Tyler Duffey and 23-year-old southpaw Adalberto Mejia are also waiting in the wings. Both have made convincing cases for their inclusion on the pitching staff this spring, but Duffey is coming off of a 6.43 ERA in 2016 and Mejia lacks some of the polish that Berrios offers. Still, stockpiling young pitching depth isn’t a bad thing, and could give the Twins a cushion in the event of injury or collapse down the stretch.

The bullpen outperformed the rotation in 2016, which is saying… something, though maybe not a lot. They still finished the year with a cumulative 4.63 ERA, good for last place among their American League rivals, and delivered just 2.1 fWAR while taking on the fourth-most innings in the league. The standout performer was 28-year-old righty Ryan Pressly, who worked a 3.70 ERA, 2.7 BB/9 and 8.0 SO/9 in 75 1/3 innings last year. In light of Ryan Vogelsong’s recent departure from the club, the Twins will round out their bullpen with left-hander Craig Breslow, who turned in a 4.50 ERA with the Marlins in 2016 and is looking for a bounce-back season of his own after reworking his delivery at age 36.

For now, it looks like Falvey and the Twins’ front office are taking a wait-and-see approach to the coming season, which bodes well for their long-term vision (assuming most of their young prospects pan out) and not so well for their chances of moving up in the division in the next year or so. That could change by the trade deadline if they can secure a worthwhile return for Dozier, though given the rumors of their understandably high asking price, it could take more than a few months to get a deal in place.

Even assuming that all the chips fall in the Twins’ favor in 2017 — prospects start hitting consistently, the rotation solidifies, and Falvey loosens the purse strings enough to net more established contenders — it’s difficult to imagine anything more than a fourth-place finish for the club as they continue to rebuild and regroup. Barring any major improvements on the inconsistent, if occasionally productive, lineup of 2016, another last-place finish feels imminent.

Prediction: Fifth place, AL Central.